Phathom Pharmaceuticals Inc (PHAT)

7.50 -0.11 (-1.45%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Phathom Pharmaceuticals Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Merck & Co Inc Upgrade
Galectin Therapeutics Inc --
AbbVie Inc Upgrade
Poseida Therapeutics Inc Upgrade
Janux Therapeutics Inc Upgrade

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade